The store will not work correctly when cookies are disabled.
2,7-dihydroxy-4-(4-methoxybenzoyl)-5-methylcyclohepta-2,4,6-trien-1-one
ID: ALA4520450
PubChem CID: 137253746
Max Phase: Preclinical
Molecular Formula: C16H14O5
Molecular Weight: 286.28
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(C(=O)c2cc(O)c(=O)c(O)cc2C)cc1
Standard InChI: InChI=1S/C16H14O5/c1-9-7-13(17)16(20)14(18)8-12(9)15(19)10-3-5-11(21-2)6-4-10/h3-8H,1-2H3,(H2,17,18,20)
Standard InChI Key: GRTJCMZVJLHIRE-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
3.8037 -18.0303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5453 -17.6872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2838 -18.0499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6086 -18.8310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4605 -18.8506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1209 -19.4759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9432 -19.4817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5548 -16.8660 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.9309 -17.5456 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.1668 -17.5090 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.7560 -20.2133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2902 -20.2257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8188 -20.9044 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.1002 -20.2960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4411 -21.0327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2504 -21.1033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7171 -20.4365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3689 -19.6971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5607 -19.6301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5314 -20.5061 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.8782 -21.2460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
1 4 2 0
3 5 2 0
4 6 1 0
5 7 1 0
6 7 2 0
2 8 2 0
3 9 1 0
1 10 1 0
6 11 1 0
7 12 1 0
12 13 2 0
12 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
17 20 1 0
20 21 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 286.28 | Molecular Weight (Monoisotopic): 286.0841 | AlogP: 2.01 | #Rotatable Bonds: 3 |
Polar Surface Area: 83.83 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.12 | CX Basic pKa: ┄ | CX LogP: 2.12 | CX LogD: 2.11 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.84 | Np Likeness Score: 0.00 |
References
1. Berkowitz AJ, Franson AD, Gazquez Cassals A, Donald KA, Yu AJ, Garimallaprabhakaran AK, Morrison LA, Murelli RP.. (2019) Importance of lipophilicity for potent anti-herpes simplex virus-1 activity of α-hydroxytropolones., 10 (7): [PMID:31391890] [10.1039/C9MD00225A] |